Prevalence of interfering substances with point-of-care glucose testing in a community hospital

American Journal of Health-System Pharmacy

Volumn 66, Issue 2, 2009, Pages 167-170

  Eastham, John H ^a,b   Mason, Debra ^d   Barnes, Deborah L ^c   Kollins, Jerry ^a  

^a PALOMAR POMERADO HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Quality and Patient Safety

^d NONE

Author keywords

Dextrose; Hospitals; Tests, laboratory

Indexed keywords

BILIRUBIN; GLUCOSE; GLUCOSE DEHYDROGENASE; INSULIN; PARACETAMOL; PYRROLOQUINOLINEQUINONE; TRIACYLGLYCEROL; URIC ACID;

ARTICLE; COMMUNITY HOSPITAL; GLUCOSE TOLERANCE TEST; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; PREVALENCE; PRIORITY JOURNAL;

EID: 58449090580     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070512     Document Type: Article

References (23)

1. Wiener K. Potential for error from underfilling Glucometer Elite test strips. Diabet Med. 2000; 17:555-6.
2. Lewandrowski E, Mac Millan D, Misiano D et al. Process improvement for bedside capillary glucose testing in a large academic medical center: the impact of new technology on point-of-care testing. Clin Chim Acta. 2001; 307:175-9.
3. Bamberg R, Schulman K, MacKenzie M et al. Effect of adverse storage conditions on performance of glucometer test strips. Clin Lab Sci. 2005; 18:203-9.
4. McEnroe RJ, Burritt MF, Powers DM et al. Interference testing in clinical chemistry; approved guideline. 2nd ed. Wayne, PA: Clinical and Laboratory Standards; 2005.
5. In vitro diagnostic test systems - requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2003(E). Geneva, Switzerland: International Organization for Standardization.
6. ACCU-CHEK Comfort Curve test strips package insert. Indianapolis, IN: Roche Diagnostics; 2007.
7. Floré K, Delanghe J. Icodextrin: a major problem for glucose dehydrogenase-based glucose point of care testing systems. Acta Clin Belg. 2006; 61:351-4. In Dutch.
8. EXTRANEAL package insert. Deerfield, IL: Baxter Healthcare Corporation; 2008 Jun.
9. College of American Pathologists. Bedside glucose testing systems. www.cap.org/apps/docs/cap-today/surveys/0408-Glucose-Survey.pdf (accessed 2008 Oct 30).
10. Precision PCx Plus test strips package insert. Bedford, MA: Abbott Laboratories, Medisense Products; 2003 Jan.
11. SureStep Pro test strips package insert. Milpitas, CA: LifeScan; 2004 Jan.
12. StatStrip test strips package insert. Waltham, MA: Nova Biomedical; 2008 Mar.
13. Southworth MR, Kortepeter C, Lu S. Minimizing hypoglycemia attributed to an interaction between icodextrin peritoneal dialysis solution and blood glucose test strips: utility of a U.S. postmarketing safety program. Paper presented at FDA Science Forum, Washington, DC; 2005 Apr 27.
14. Australian Government Department of Health and Ageing Therapeutic Goods Administration. TGA news issue 46 (Apr 2005) - medical device incident investigations. www.tga.gov.au/docs/html/tganews/news46/iris.htm (accessed 2008 Oct 30).
15. Institute for Safe Medication Practices. Medication safety alert. Be aware of false glucose results with point-of-care testing. www.ismp.org/ newsletters/acutecare/articles/20050908.asp (accessed 2008 Oct 30).
16. Gaines AR, Pierce LR, Bernhardt PA. Food and Drug Administration. Center for Biologics Evaluation and Research. Fatal iatrogenic hypoglycemia. Falsely elevated blood glucose readings with a point-of-care meter due to a maltose-containing intravenous immune globulin product. www.fda.gov/cber/safety/ glucfalse.htm (accessed 2008 Oct 30).
17. Medicines and Healthcare Products Regulatory Agency. Medical device alert. Point-of-care and home-use blood glucose meters. www.mhra.gov.uk/ Publications/Safetywarnings/MedicalDeviceAlerts/CON2031807 (accessed 2008 Oct 30).
18. Food and Drug Administration. Blood Products Advisory Committee transcripts. Nov 4, 2005. www.fda.gov/ohrms/dockets/ac/03/briefing/4014b1-20- reprintsforabbreviatedhistory.pdf (accessed 2008 Oct 30).
19. Dungan K, Chapman J, Braithwaite SS et al. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007; 30:403-9.
20. Schleis TG. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy. 2007; 27:1313-21.
21. Louie RF, Tang Z, Sutton DV et al. Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med. 2000; 124:257-66.
22. Soldin SJ, Devairakkam PD, Aagarwalla PK. Evaluation of the Abbott PCx point of care glucose analyzer in a pediatric hospital. Clin Biochem. 2000; 33:319-21.
23. Cartier LJ, Leclerc P, Pouliot M et al. Toxic levels of acetaminophen produce a major positive interference on Glucometer Elite and Accu-chek Advantage glucose meters. Clin Chem. 1998; 44:893-4.